182 related articles for article (PubMed ID: 23920875)
1. Standardizing drug adverse event reporting data.
Wang L; Jiang G; Li D; Liu H
Stud Health Technol Inform; 2013; 192():1101. PubMed ID: 23920875
[TBL] [Abstract][Full Text] [Related]
2. Standardizing adverse drug event reporting data.
Wang L; Jiang G; Li D; Liu H
J Biomed Semantics; 2014; 5():36. PubMed ID: 25157320
[TBL] [Abstract][Full Text] [Related]
3. AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.
Grigoriev I; zu Castell W; Tsvetkov P; Antonov AV
Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):795-801. PubMed ID: 24677538
[TBL] [Abstract][Full Text] [Related]
4. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
5. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.
Gandhi PK; Gentry WM; Bottorff MB
Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229
[TBL] [Abstract][Full Text] [Related]
7. Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
Huang L; Zalkikar J; Tiwari RC
J Biopharm Stat; 2013; 23(1):178-200. PubMed ID: 23331230
[TBL] [Abstract][Full Text] [Related]
8. Data mining for signal detection of adverse event safety data.
Chen HC; Tsong Y; Chen JJ
J Biopharm Stat; 2013; 23(1):146-60. PubMed ID: 23331228
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
10. How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
Khadem TM; van Manen RP; Brown J
Pharmacotherapy; 2014 Dec; 34(12):1324-9. PubMed ID: 25421400
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database.
Gandhi PK; Gentry WM; Bottorff MB
Semin Arthritis Rheum; 2013 Jun; 42(6):562-6. PubMed ID: 23352248
[TBL] [Abstract][Full Text] [Related]
12. Analyzing categorical information in two publicly available drug terminologies: RxNorm and NDF-RT.
Pathak J; Chute CG
J Am Med Inform Assoc; 2010; 17(4):432-9. PubMed ID: 20595311
[TBL] [Abstract][Full Text] [Related]
13. Building a knowledge base of severe adverse drug events based on AERS reporting data using semantic web technologies.
Jiang G; Wang L; Liu H; Solbrig HR; Chute CG
Stud Health Technol Inform; 2013; 192():496-500. PubMed ID: 23920604
[TBL] [Abstract][Full Text] [Related]
14. Adverse event profiles of 5-fluorouracil and capecitabine: data mining of the public version of the FDA Adverse Event Reporting System, AERS, and reproducibility of clinical observations.
Kadoyama K; Miki I; Tamura T; Brown JB; Sakaeda T; Okuno Y
Int J Med Sci; 2012; 9(1):33-9. PubMed ID: 22211087
[TBL] [Abstract][Full Text] [Related]
15. An experimental investigation of masking in the US FDA adverse event reporting system database.
Wang HW; Hochberg AM; Pearson RK; Hauben M
Drug Saf; 2010 Dec; 33(12):1117-33. PubMed ID: 21077702
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.
Kadoyama K; Kuwahara A; Yamamori M; Brown JB; Sakaeda T; Okuno Y
J Exp Clin Cancer Res; 2011 Oct; 30(1):93. PubMed ID: 21970649
[TBL] [Abstract][Full Text] [Related]
17. Data incompatibility of adverse event reports electronically submitted to the AERS database.
Glass LM
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):212-3. PubMed ID: 18236510
[No Abstract] [Full Text] [Related]
18. Signal detection in FDA AERS database using Dirichlet process.
Hu N; Huang L; Tiwari RC
Stat Med; 2015 Aug; 34(19):2725-42. PubMed ID: 25924820
[TBL] [Abstract][Full Text] [Related]
19. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants.
Ehrenpreis ED; Sifuentes H; Ehrenpreis JE; Smith ZL; Marshall ML
Expert Opin Drug Saf; 2012 Mar; 11(2):177-83. PubMed ID: 22316142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
